发明名称 COMPOSITION FOR NASAL ABSORPTION
摘要 <p>It is intended to provide a composition for nasal administration which shows an extremely low expression ratio of side effects, quickly exerts an analgesic effect and has an excellent bioavailability, compared with preparations for oral administration. A composition for nasal absorption wherein an opiopid analgesic in an effective dose is uniformly dispersed in a carrier comprising calcium carbonate and/or calcium phosphate and having an average grain size of 500 mum or less and adhered/boded thereto.</p>
申请公布号 WO2004006929(A1) 申请公布日期 2004.01.22
申请号 WO2003JP08838 申请日期 2003.07.11
申请人 YANAGAWA, AKIRA;TAIHO PHARMACEUTICAL CO., LTD. 发明人 YANAGAWA, AKIRA
分类号 A61K9/16;A61K9/00;A61K31/485;A61K47/02;A61K47/04;A61P25/04;(IPC1-7):A61K31/485;A61K47/12;A61K9/72;A61K9/14 主分类号 A61K9/16
代理机构 代理人
主权项
地址